Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden.

Oncotarget · 2015 · PMC4741784 · PMID 26392335

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not quite reach statistical significanceno p-value reported

The tumors treated with 1 μg PrAg-PCIS toxin also showed reduced staining and loss of viability, which did not quite reach statistical significance relative to the vehicle treated control group (Figures 8A, 8E ).

also in 679 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.